Logo image
Non-genetic engineering of cells for drug delivery and cell-based therapy
Journal article   Peer reviewed

Non-genetic engineering of cells for drug delivery and cell-based therapy

Qun Wang, Hao Cheng, Haisheng Peng, Hao Zhou, Peter Y. Li and Robert Langer
Advanced drug delivery reviews, v 91
30 Aug 2015
PMID: 25543006

Abstract

Life Sciences & Biomedicine; Pharmacology & Pharmacy; Science & Technology
Cell-based therapy is a promising modality to address many unmet medical needs. In addition to genetic engineering, material-based, biochemical, and physical science-based approaches have emerged as novel approaches to modify cells. Non-genetic engineering of cells has been applied in delivering therapeutics to tissues, homing of cells to the bone marrow or inflammatory tissues, cancer imaging, immunotherapy, and remotely controlling cellular functions. This new strategy has unique advantages in disease therapy and is complementary to existing gene-based cell engineering approaches. A better understanding of cellular systems and different engineering methods will allow us to better exploit engineered cells in biomedicine. Here, we review non-genetic cell engineering techniques and applications of engineered cells, discuss the pros and cons of different methods, and provide our perspectives on future research directions. (C) 2014 Elsevier B.V. All rights reserved.

Metrics

5 Record Views
218 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pharmacology & Pharmacy
Logo image